Patients with ovarium cancer

We have conducted a phase I long peptide vaccination trial with p53 peptides in Montanide adjuvant in patients with colorectal cancer or ovarium cancer.

created over 15 years ago (5 February 2010)    last modified over 13 years ago (28 September 2011)   [ RDF ]   [ RelFinder ]